drugset / Trial / NCT03905837

Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery

NCT03905837 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to analyze the impact of the intravenous (IV) or paravertebral (PV) lidocaine administration during the intraoperative period of lung resection surgery on the appearance of postoperative complications. We design a randomized, controlled and blinded study to be performed in 153 patients with 3 arms: 1) Lidocaine IV + PV saline 2) saline IV + PV lidocaine, 3) remifentanil IV + PV saline. Perioperative analysis of inflammatory biomarkers in bronchoalveolar lavage and serum. Follow-up of the postoperative course, especially the appearance of postoperative complications according to the revised Clavien-Dindo classification for thoracic surgery, as well as other relevant clinical results.

Timeline

Start
2019-01-28
Primary completion
2021-06-02
Completion
2021-07-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.1 ml Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Subject Lidocaine Other / unclassified 2 % Intravenous
Comparator Remifentanil Small molecule 0.1 mg/kg Intravenous

Indications